trending Market Intelligence /marketintelligence/en/news-insights/trending/dnhcvq-eb-quqvadmgbyta2 content esgSubNav
In This List

Oncimmune names chief medical, strategy officer

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Oncimmune names chief medical, strategy officer

Oncimmune Holdings plc named Adam Hill as its chief medical and chief strategy officer.

Hill, who will assume the positions April 9, most recently worked with McLaren Applied Technologies in a similar capacity.

He is also the former chief medical officer of Sectra AB.

Nottingham, U.K.-based Oncimmune is looking to commercialize its EarlyCDT platform to detect cancer.